Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX3 | P56373 | 1/20 | 0.43 |
| ▸ | DHODH | Q02127 | 3/20 | 0.43 |
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.42 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | GFER | P55789 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL724677 | 0.87 | ASAH1 (0.54) | PARP1ASAH1ALDH1A1KMT2AL3MBTL1 | |
| SCHEMBL9880613 | 0.86 | HTR2C (0.43) | P2RX3PARP1ASAH1ALDH1A1P2RX4 | |
| SCHEMBL9880610 | 0.82 | ASAH1 (0.47) | DHODHASAH1ALDH1A1P2RX4KMT2A | |
| SCHEMBL24514645 | 0.81 | PARP1 (0.41) | PARP1ASAH1ALDH1A1P2RX4KMT2A | |
| SCHEMBL18031571 | 0.78 | KCNMA1 (0.54) | P2RX3DHODHALDH1A1P2RX4GFER | |
| SCHEMBL24576309 | 0.78 | ASAH1 (0.47) | DHODHASAH1ALDH1A1P2RX4KMT2A | |
| SCHEMBL21082271 | 0.77 | MARK4 (0.46) | DHODHPARP1ALDH1A1P2RX4KMT2A | |
| SCHEMBL7166112 | 0.77 | TFPI2 (0.44) | P2RX3ALDH1A1P2RX4ADORA3KMT2A | |
| SCHEMBL9880604 | 0.77 | GSK3B (0.56) | PARP1ALDH1A1P2RX4KMT2AMEN1 | |
| SCHEMBL24514807 | 0.75 | ALDH1A1 (0.41) | P2RX3PARP1ASAH1ALDH1A1P2RX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220190296-A1 | LIGHT-EMITTING DEVICE AND AN ELECTRONIC DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-06-16 | — | — | US | disclosed |
| US-11056664-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11056664-B2 | Organic light-emitting device | EML4, L1CAM, OR10J3 | P2RX3 1442/4885DHODH 1845/4885PARP1 1801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.